Peripheral vascular disease and hypertension: a forgotten association? (Q34314049)

1 August 2017

1 reference

title

Peripheral vascular disease and hypertension: a forgotten association? (English)

1 reference

1 August 2017

1 reference

Makin A

1

1 reference

1 August 2017

Lip GY

series ordinal

2

1 reference

1 August 2017

Silverman S

series ordinal

3

1 reference

1 August 2017

Beevers DG

series ordinal

4

1 reference

1 August 2017

publication date

1 July 2001

1 reference

Journal of Human Hypertension

1 August 2017

published in

1 reference

1 August 2017

volume

15

1 reference

1 August 2017

issue

7

1 reference

1 August 2017

page(s)

447-454

1 reference

The demographics of claudication and the aging of the American population

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Prevalence of intermittent claudication and its effect on mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Intermittent claudication in 8343 men and 21-year specific mortality follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Role of blood pressure in cardiovascular morbidity and mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

An atherosclerosis risk factor assessment program for patients with peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Relation of a postmortem renal index of hypertension to atherosclerosis and coronary artery size in young men and women. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Evidence of early changes of the brachial artery circulation in borderline hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

The prevalence of peripheral arterial disease in a defined population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Peripheral arterial disease in the elderly: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Epidemiology of intermittent claudication in middle-aged men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Intermittent claudication. A risk profile from The Framingham Heart Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Systolic hypertension: a pathogenetic entity. Significance and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Mortality in patients of the Glasgow Blood Pressure Clinic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Intermittent claudication. Incidence in the Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Relation of a postmortem renal index of hypertension to atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterol--the Reykjavik Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Mortality over four years in SHEP participants with a low ankle-arm index

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Expansion rates of small abdominal aortic aneurysms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Renal artery stenosis: a common and important problem in patients with peripheral vascular disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Effect of renal-artery stenting on progression of renovascular renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Unsuspected renal artery stenosis in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Risk factors for peripheral vascular disease in hypertensive subjects with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Blood Pressure in Navajo Indians and Its Association With Type 2 Diabetes and Renal and Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with the doppler ultrasonic technique

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Abnormal arterial flow pattern in untreated essential hypertension: possible link with the development of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Role of oxidised low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

The pathogenesis of atherosclerosis--an update

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Platelet-induced migration of smooth muscle cells under shear stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Does hypertension confer a prothrombotic state? Virchow's triad revisited

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Infectious agents and atherosclerotic vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Chlamydia pneumoniae antibodies in severe essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Guidelines for management of hypertension: report of the third working party of the British Hypertension Society

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Peripheral vascular effects of beta-blockers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Captopril for the Treatment of Patients with Hypertension and Peripheral Vascular Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Efficacy of doxazosin in specific hypertensive patient groups

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Effect of felodipine on regional blood supply and collateral vascular resistance in patients with peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Effect of verapamil in intermittent claudication A randomized, double-blind, placebo-controlled, cross-over study after individual dose-response assessment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

The effects of nifedipine on blood flow in peripheral vascular disease of the lower limbs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Assessment of captopril and nicardipine effects on chronic occlusive arterial disease of the lower extremity using Doppler ultrasound

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Specific calcium antagonists in the treatment of peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Morbidity, Mortality, and Antihypertensive Treatment Effects by Extent of Atherosclerosis in Older Adults With Isolated Systolic Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Relationship between small-artery structure and systolic, diastolic and pulse pressure in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Screening for abdominal aortic aneurysm during transthoracic echocardiography in a hypertensive patient population.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Mass or high-risk screening for abdominal aortic aneurysm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Prevalence of abdominal aortic aneurysm associated with hypertension in an urban population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001209

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001209

1 reference

Dimensions Publication ID

1 August 2017

1001633179

0 references

1 reference